News
GSK will acquire Boston Pharmaceuticals’ lead asset, efimosfermin alfa, a phase III-ready investigational specialty medicine.
Forge Biologics has entered an AAV development and manufacturing agreement to help advance Fractyl Health’s Rejuva platform.
Ecolab Life Sciences has opened its new US Bioprocessing Applications Laboratory in King of Prussia, Pennsylvania.
Thermo Fisher Scientific has introduced the Applied Biosystems MagMAX Pro HT NoSpin Plasmid MiniPrep Kit to address the ...
Hansa Biopharma AB has appointed Maria Törnsén as Chief Operating Officer (COO) and President U.S., effective May 19.
Xmoor Pharma has entered into a strategic partnership with KU Leuven to support a new cell and gene therapy hub.
Segmed Inc., a leader in real-world imaging data for research and AI development, has appointed David Gascoigne as Chief ...
Recipharm and ProductLife Group (PLG) have joined forces to support (bio)pharmaceutical companies in accelerating time to ...
Genentech has announced plans to invest more than $700 million in a new 700,000 square foot drug manufacturing facility.
Rockwell Automation, a company dedicated to industrial automation and digital transformation, has launched FactoryTalk ...
Bora Pharmaceuticals Co., Ltd., a pharmaceutical manufacturer, has appointed Jean-Baptiste (JB) Agnus as Chief Commercial ...
Stylus Medicine Inc., a biotechnology company dedicated to developing transformative in vivo genetic medicines, has emerged ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results